作者:O. V. Goryunova、G. M. Zakharchuk、O. S. Zhukova、L. V. Fetisova、N. E. Kuzmina
DOI:10.1134/s106816201401004x
日期:2014.1
N-amino end-group, in DMF at 130°C, wherein the nitrogen atom of peptide amino group replaces oxygen O6 in furan ring of heterocycle and is embedded in imide nitrogen atom of pyrrole N6. The ability of the obtained compounds to inhibit growth of SKOV3 human ovarian carcinoma cells was studied, only derivative with radical >N6-(CH2)3-CO-L-Ala-OMe showed cytotoxic activity with an inhibitory concentration
合成N12-核糖基-吲哚并[2,3-a]吡咯并[3,4-c]咔唑-5,7-二酮的N6-衍生物作为潜在的抗肿瘤剂,其中杂环的N6-吡咯部分的原子为通式> N6-(CH2)n-CO-Ala /βAla-OMe(n = 2或3)包含在二肽残基中。这些化合物是由13-甲基-12-(2,3,4-三-O-乙酰基-β-D-核吡喃糖基)吲哚并[2,3-a]呋喃并[3,4-c]咔唑在130°C的DMF中,具有未取代的N-氨基端基的二肽的5,7-二酮,其中肽氨基的氮原子取代杂环呋喃环中的氧O6,并嵌入吡咯的酰亚胺氮原子中N6 研究了获得的化合物抑制SKOV3人卵巢癌细胞生长的能力,仅具有基团>